Skip to main content
. 2017 Jun 29;16:259. doi: 10.1186/s12936-017-1908-7

Table 1.

Groups of mice, vaccine formulations, doses and administration protocols used in Experiments I, II and III

 Group Yeast lysate dose (YU) Adjuvant Number of mice Number of immunizations
Experiment I
 N-PbCS 30 No 8 5
 PbCS 30a No 8 5
 N 30a No 6 5
 WT 30 No 6 5
 Naive / / 8 /
Experiment II
 N-PbCS 30 No 6 3
 N-PbCS 30 No 6 5
 N-PbCS 150 No 6 5
 N-PbCS 300 No 6 5
 N 30a No 6 3
 N 30a No 6 5
 N 150a No 6 5
 N 300a No 6 5
 WT 30 No 4 3
 WT 30 No 4 5
 WT 150 No 4 5
 WT 300 No 4 5
 Naive / / 8 /
Experiment III
 N-PbCS 50 Yes 6 3
 N-PbCS 100 Yes 6 3
 N-PbCS 150 Yes 6 3
 N 50a Yes 6 3
 N 100a Yes 6 3
 N 150a Yes 6 3
 WT 150 Yes 6 3
 Alum / Yes 6 3
 Naive / / 6 /
aDiluted with WT yeast according to the following calculation:
Expression level, ng/YU Mol. weight, g/mol Expression level, pmol/YU Folds diluted with WT to match N-PbCS Antigen dose in 30 YU, ng
N-PbCS 12 91,32 131 / 360
PbCS 16 33,24 481 3,7 130
N 870 58,08 14,979 114,0 230

1 YU = 107 cells